AvroBio PEG Ratio

AvroBio (AVRO) currently reports a PEG ratio of -71.51. That is below the Healthcare sector average of 2.89. Use the charts on this page to explore AvroBio's PEG ratio history and peer comparisons.

AvroBio's PEG ratio of -71.51 is lower than the Healthcare sector average of 2.89. That is roughly 2573.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates AvroBio's market price to a fundamental measure such as earnings, sales, or book value. At -71.51, AVRO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -71.51, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 2.89. From there, open related valuation or income-statement pages for AvroBio, and consider following AVRO for alerts when major investors trade the stock.

AvroBio is classified in the Healthcare sector. On PEG ratio, it currently shows -71.51 versus a sector average near 2.89. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVRO with unrelated industries.